Navigation Links
Taking the needle's sting out of diabetes
Date:8/10/2009

Found in 30% of all human cancer tumors, the Ras protein literally "drives cells crazy," says Prof. Yoel Kloog, the dean of the Faculty of Life Sciences at Tel Aviv University. Prof. Kloog was the first in the world to develop an effective anti-Ras drug against pancreatic cancer, currently in clinical trials. Now, new research published in the June issue of the European Journal of Pharmacology shows that the drug might be able to slow the progression of diabetes as well.

Prof. Kloog's student Adi Mor of TAU's Department of Neuro-biochemistry and Sackler School of Medicine has modified Prof. Kloog's anti-Ras FTS compound to develop what could be the first tablet-based treatment for children and adults with Type 1 diabetes. Early results show that FTS is effective in restoring insulin production in animal models ― which could spell an end to the daily needle injections endured by diabetics.

"Our anti-Ras compound has shown very positive results in inhibiting diabetes," says Mor. And given the drug's history FTS has already passed toxicity studies for other diseases and disorders it has the potential to fast-track through FDA regulatory hurdles, skipping straight to Phase II clinical trials. A new drug for diabetes could be ready in as little as five years' time.

Helping the immune system do its job

Previous studies by Prof. Kloog's lab found that the FTS compound is effective against autoimmune diseases such as multiple sclerosis and lupus, "but the mechanism of its effects on immune cells was not well understood," says Mor. "I wanted to see if there was a connection between Ras and the regulation of the immune system, and if so if FTS could help regulate it to prevent or slow diabetes."

Through treating cells with the Tel Aviv University FTS compound, Mor was able to find and isolate an important immune system regulator protein called Foxp3. This protein keeps T cells in the immune system in check.
'/>"/>

Contact: George Hunka
ghunka@aftau.org
212-742-9070
American Friends of Tel Aviv University
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Mathematics taking guesswork out of plastic surgery tissue transfer
2. Looking to Shape Up for Summer? The Solution May Be the Steps Youre Already Taking
3. Swine Flu Vaccine Taking Longer Than Expected
4. Drug Limits Stomach Trouble in Patients Taking Low-Dose Aspirin
5. Looking to Shape up for Summer? The Solution May be the Steps Youre Already Taking
6. Taking Aim at Relapse of Leukemia in Kids
7. Value of Taking Aspirin to Cut Heart Risk Varies
8. Financial Distress Taking Toll on Employee Health
9. Taking a Bite Out of Rabies: Merial Provides Rabies Awareness and Prevention Training to Noahs Wish Pet Disaster Relief Organization
10. Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole?
11. Taking folic acid for a year before pregnancy may reduce risk of preterm birth
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Taking the needle's sting out of diabetes
(Date:11/18/2014)... Financing for Development Corp. (F4D), ... for international development, has announced the first cohort ... Directors: Mr. John Skibiak of the Reproductive Health ... Challenge Corporation, Mr. Pape Gaye of IntraHealth International, ... Aron Betru of Financing for Development, and Mr. ...
(Date:11/18/2014)... La Vergne, TN (PRWEB) November 18, 2014 ... contract packaging company for pharmaceutical, nutraceutical, dietary supplements ... has been awarded NSF International’s Good Manufacturing Practices ... substances. , Earning GMP registration from NSF International ... exceeds the safety and quality compliance requirements of ...
(Date:11/18/2014)... News) -- Hispanic women who,ve had at least five children ... heart trouble than those who,ve had fewer children or none, ... by Shivani Aggarwal of Wake Forest School of Medicine analyzed ... Miami, New York City and San Diego. About 12 percent ... A type of heart trouble called ventricular diastolic dysfunction ...
(Date:11/18/2014)... recently, insect-transmitted Chagas disease was found mainly in Latin America ... the United States over the past few years. ... of the "kissing bug," which feeds on the faces of ... common bedbugs might be carriers as well. "We,ve shown ... next step is to determine whether they are, or will ...
(Date:11/17/2014)... (PRWEB) November 17, 2014 Home Care ... leading provider of non-medical, in-home senior care, is advising ... shot. , Aging typically weakens the immune system and ... as the flu. This is a greater concern at ... are more prevalent; during last year’s influenza season (November ...
Breaking Medicine News(10 mins):Health News:Financing for Development Corp. (F4D) Announces Board of Directors 2Health News:Financing for Development Corp. (F4D) Announces Board of Directors 3Health News:Financing for Development Corp. (F4D) Announces Board of Directors 4Health News:A+ Secure Packaging, LLC Earns NSF International Good Manufacturing Practices (GMP) Registration for Dietary Supplements and Certification for Sport 2Health News:Certain Heart Dysfunction More Likely in Hispanic Women With Many Kids: Study 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 3Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Encourages Seniors to Get Annual Flu Shot 2Health News:Home Care Assistance – Halton/Peel Region, a Top Provider of In-Home Care, Encourages Seniors to Get Annual Flu Shot 3
... crispiness , MONDAY, Sept. 24 (HealthDay News) -- Deep-fried fish ... to Japanese scientists who say they,ve concocted a recipe for ... & Industry magazine, the Tokyo University of Technology team ... frying process. They then altered the water content and frying ...
... ... Care Highlight Trends, WASHINGTON, Sept. 24 Millions of ... health care,benefits as this year,s open enrollment season rapidly approaches. ... care,costs, employees should take the time to review and evaluate ...
... heart surgery used routinely available hospital data that were ... which questions the validity of such data being made ... of information gathering used in the study had underestimated ... study, published in 2004, Oxford had been singled out ...
... treatment for endometrial cancer can be significantly improved by ... internally using a vaginal cylinder, the European Cancer Conference ... Nout, from the clinical oncology department of the Leiden ... quality of life benefit would be an important factor ...
... Downloadable Tools Can Help Communities Protect Citizens by Enhancing Their ... ... health planners,have a new tool to help them prepare for one of ... Center for Infectious Disease Research & Policy (CIDRAP) at,the University of Minnesota ...
... Nation,s fourth largest health insurer continues expansion of ... data to optimize member health, reduce, unnecessary health ... CHICAGO, Sept. 24 Health Care Service ... Shield plans in Illinois,New Mexico, Oklahoma and Texas, ...
Cached Medicine News:Health News:Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season 2Health News:Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season 3Health News:Watson Wyatt Identifies Major Benefit Trends During Open Enrollment Season 4Health News:New study questions the validity of publishing hospital mortality rates 2Health News:Internal radiotherapy better than external for quality of life in endometrial cancer patients 2Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 2Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 3Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 4Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 5Health News:Health Care Service Corporation Provides Personal Clinical Summaries to Members of its Blue Cross and Blue Shield plans in Illinois, New Mexico, Oklahoma and Texas 2
(Date:11/18/2014)...  Palatin Technologies, Inc. (NYSE MKT: PTN), ... therapeutics for the treatment of diseases with ... today announced results for its first quarter ... Recent Highlights , Bremelanotide development for ... total upfront payment - License, co-development and ...
(Date:11/18/2014)... DIEGO , Nov. 18, 2014  Renova ... for congestive heart failure and other chronic diseases, ... its board of directors. The company also completed ... New board member brings decades ... is a life sciences executive with more than ...
(Date:11/18/2014)... , Nov. 18, 2014 Tocagen Inc. ... overall survival and progression free survival at six months ... Toca 511 & Toca FC, compared to published benchmarks. ... of primary brain cancer. The data were delivered in an ... Meeting and Education Day of the Society for Neuro-Oncology ...
Breaking Medicine Technology:Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014 2Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014 3Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014 4Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014 5Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014 6Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014 7Renova Therapeutics welcomes new board member, raises $7.52 million in Series C financing round 2Renova Therapeutics welcomes new board member, raises $7.52 million in Series C financing round 3Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 2Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 3Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 4Interim Data Show Increased Median Overall Survival of Recurrent Brain Cancer Patients Treated with Tocagen's Toca 511 & Toca FC, Compared to Published Benchmarks 5
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: